OrganiGram Financial Statements From 2010 to 2025
| OGI Stock | USD 1.27 0.08 5.93% |
Gross Profit 54.6 M | Profit Margin | Market Capitalization 160.9 M | Enterprise Value Revenue 1.1534 | Revenue |
Check OrganiGram Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OrganiGram Holdings' main balance sheet or income statement drivers, such as , as well as many indicators such as . OrganiGram financial statements analysis is a perfect complement when working with OrganiGram Holdings Valuation or Volatility modules.
OrganiGram |
OrganiGram Holdings Company Return On Equity Analysis
OrganiGram Holdings' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current OrganiGram Holdings Return On Equity | -0.55 |
Most of OrganiGram Holdings' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OrganiGram Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, OrganiGram Holdings has a Return On Equity of -0.5453. This is 97.73% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is 75.9% higher than that of the company.
OrganiGram Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining OrganiGram Holdings's current stock value. Our valuation model uses many indicators to compare OrganiGram Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OrganiGram Holdings competition to find correlations between indicators driving OrganiGram Holdings's intrinsic value. More Info.OrganiGram Holdings is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the OrganiGram Holdings' earnings, one of the primary drivers of an investment's value.About OrganiGram Holdings Financial Statements
Investors use fundamental indicators, such as OrganiGram Holdings' revenue or net income, to determine how well the company is positioned to perform in the future. Although OrganiGram Holdings' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada. Organigram Hlds is traded on NASDAQ Exchange in the United States.
Currently Active Assets on Macroaxis
When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock:Check out the analysis of OrganiGram Holdings Correlation against competitors. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.34) | Revenue Per Share 1.606 | Quarterly Revenue Growth 0.172 | Return On Assets (0.06) | Return On Equity |
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.